Weekly shot challenge: new drug takes on standard insulin
NCT ID NCT07165223
Summary
This study is testing a new injectable diabetes drug, GZR4, against a once-weekly insulin. It aims to see which one better controls blood sugar levels, is safer, and affects weight in people with type 2 diabetes who are already using insulin. About 300 adults will participate to help determine if GZR4 could be a useful new treatment option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gan & Lee Pharmaceuticals Shandong Co., Ltd.
RECRUITINGLinyi, Shandong, 276000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.